It is that time of the year with creepy/crawly ticks running rampant. This presents an excellent opportunity to go over some of my Lyme disease clinical practice pearls! You never know when these might show up on a board exam! Lyme Disease Clinical Practice Pearls...
A new SGLT2i is now on the market, promoting a new option for diabetes management. Bexagliflozin (Brenzavvy) got FDA approval in January of this year adding it to the list of SGLT2 inhibitors. With a few already on the scene, it bears the question, is bexagliflozin...
Earlier this month the FDA approved Rexulti (Brexpiprazole) for the treatment of agitation in patients with dementia due to Alzheimer’s. Originally approved as an atypical antipsychotic used for schizophrenia, or an adjunct therapy for major depressive disorder,...
Buspirone is an anti-anxiety medication that can be used for chronic management. I’ll outline some of the most important clinical pearls and share some anecdotal education in this blog post. The Good – Buspirone Clinical Pearls Buspirone is well tolerated...
We have had a wonderful response to our previous pharmacology crossword on diabetes so I figured I try this again. With the help of a pharmacy student, Kevin Laspa, we have created a free hypertension pharmacology crossword puzzle! (ANSWERS AT THE BOTTOM OF THIS POST)...
